1. Home
  2. FKWL vs LSTA Comparison

FKWL vs LSTA Comparison

Compare FKWL & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Wireless Corp.

FKWL

Franklin Wireless Corp.

HOLD

Current Price

$2.37

Market Cap

33.0M

Sector

Utilities

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

N/A

Current Price

$3.31

Market Cap

28.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FKWL
LSTA
Founded
1981
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Misc Health and Biotechnology Services
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.0M
28.9M
IPO Year
1997
2000

Fundamental Metrics

Financial Performance
Metric
FKWL
LSTA
Price
$2.37
$3.31
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$6.00
$15.00
AVG Volume (30 Days)
28.2K
55.1K
Earning Date
05-15-2026
05-11-2026
Dividend Yield
1.10%
N/A
EPS Growth
94.12
20.42
EPS
N/A
N/A
Revenue
$46,086,901.00
$35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
49.65
56.90
52 Week Low
$2.31
$1.81
52 Week High
$5.48
$5.07

Technical Indicators

Market Signals
Indicator
FKWL
LSTA
Relative Strength Index (RSI) 27.34 38.66
Support Level N/A $3.10
Resistance Level $3.79 $3.41
Average True Range (ATR) 0.08 0.06
MACD 0.00 -0.02
Stochastic Oscillator 25.64 5.48

Price Performance

Historical Comparison
FKWL
LSTA

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: